10 new life-changing biomed innovators
The first graduates of the SHAAR Innovation Hub (see previously) include , , Gento Gel-LR (sustained release antibiotics), , , , , , , and .
Gel helps bones repair faster
Israel’s OrthoTreat has developed ModulX - a gel containing both a known medication plus a plant-based compound. The gel is injected directly onto the bone as a bonding agent where it strengthens the bone and improves its physiological structure.
Lasers to reduce pain
Doctors at Israel’s Sheba Medical Center are using low-level lasers to treat soldiers and civilians for chronic pain caused from wounds sustained in the Oct 7 war. They stimulate mitochondria which releases ATP causing muscles to contract. Many patients experience up to 80% immediate improvement.
Navigating the US health system
Israel’s Healthee (see previously) helps employers and employees select and navigate the most suitable health plan. It also connects the user with round-the-clock telehealth services that are free of charge.
Diagnosing Endometriosis
Israel’s EndoCure (see previously) is developing a diagnostic tool combining AI and ultrasound that would allow physicians to clearly see the tiny lesions responsible for Endometriosis. The disease causes pelvic pain and infertility for women. It can spread to other organs and is sometimes fatal.
Edison award for cancer diagnosis
Israel’s Ibex Medical Analytics (see previously) was a bronze winner in the Diagnostic Technologies category at the 2024 Edison Awards. Ibex won the award for its Galen Breast HER2 platform, that identifies the protein responsible for the proliferation of cancer cells.
Alzheimer’s researcher sees the light
More about the groundbreaking research of Prof. Shai Rahimipour of Israel’s Bar-Ilan University (see previously). His Alzheimer’s disease target is a soluble amyloid protein that can be destroyed by nanoparticles that generate light when exposed to low-intensity X rays.
Combining software and medicine
Israel’s Remepy is developing tailored therapeutic software for mobile applications. It aims to unlock and trigger brain functions that modulate the immune system and enhance traditional medication. The hybrid digital and physical therapy should optimize the effectiveness of treatments.
US approval for retinal imaging
The US FDA has approved the fully autonomous AI from Israel’s AEYE Health (see previously) that diagnoses referable diabetic retinopathy from retinal images obtained by a handheld camera. Portable screening addresses the leading cause of blindness in the global working population.
Using AI & RNA to deliver therapies
Mana.bio (see previously) presented to the delegates of Technion UK’s tour of Israel. CEO and co-founder Yogev Debbi explained Mana’s drug delivery development, exactly 7 months after moving to its new premises on Oct 8 when 25% of their staff started IDF reserve duty.